Oxy-Rx™ and Investors

The original inventor of Bovine haemoglobin products has reinvented the manufacturing process with single use technology and novel chromatography techniques. A new manufacturing plant nears completion in the US with a further plant planned for the UK. Together with a UK based team of experienced clinical developers and clinical trials specialists, Bovine Haemoglobin will be relaunched in the UK and US shortly for veterinary and human usage.